Page last updated: 2024-08-16

sulfasalazine and adenosine

sulfasalazine has been researched along with adenosine in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (30.00)18.2507
2000's2 (20.00)29.6817
2010's5 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Cronstein, BN1
Buckley, MT; Carlin, G; Cronstein, BN; Gadangi, P; Levin, RI; Longaker, M; Montesinos, MC; Naime, D; Recht, PA1
Balter, L; Carlin, G; Cronstein, BN; Huie, MA; Montesinos, MC; Morabito, L; Resta, R; Schreibman, DM; Thompson, LF1
Ganga, A; Rodenburg, RJ; van de Putte, LB; van Lent, PL; van Venrooij, WJ1
Hashimoto, T; Konno, Y; Matsuda, Y; Nagai, M; Satsukawa, M; Taguchi, T; Yamashita, S1

Reviews

2 review(s) available for sulfasalazine and adenosine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
A novel approach to the development of anti-inflammatory agents: adenosine release at inflamed sites.
    Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 1995, Volume: 43, Issue:1

    Topics: Adenosine; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Humans; Inflammation; Methotrexate; Sulfasalazine

1995

Other Studies

8 other study(ies) available for sulfasalazine and adenosine

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
The anti-inflammatory mechanism of sulfasalazine is related to adenosine release at inflamed sites.
    Journal of immunology (Baltimore, Md. : 1950), 1996, Mar-01, Volume: 156, Issue:5

    Topics: Acyltransferases; Adenosine; Aminoimidazole Carboxamide; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Disease Models, Animal; Endothelium, Vascular; Female; Humans; Hydroxymethyl and Formyl Transferases; Mice; Mice, Inbred BALB C; Neutrophil Activation; Phosphoribosylaminoimidazolecarboxamide Formyltransferase; Ribonucleotides; Sulfasalazine

1996
Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides.
    The Journal of clinical investigation, 1998, Jan-15, Volume: 101, Issue:2

    Topics: 5'-Nucleotidase; Adenine Nucleotides; Adenosine; Adenosine Monophosphate; Animals; Anti-Inflammatory Agents; Humans; Methotrexate; Mice; Mice, Inbred BALB C; Sulfasalazine; Tumor Cells, Cultured

1998
The antiinflammatory drug sulfasalazine inhibits tumor necrosis factor alpha expression in macrophages by inducing apoptosis.
    Arthritis and rheumatism, 2000, Volume: 43, Issue:9

    Topics: Adenosine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Caspase Inhibitors; Cells, Cultured; Cysteine Proteinase Inhibitors; Humans; Macrophage Activation; Macrophages; Macrophages, Peritoneal; Methotrexate; Mice; Mice, Inbred C57BL; Sulfasalazine; Tumor Necrosis Factor-alpha

2000
In vivo assessment of the impact of efflux transporter on oral drug absorption using portal vein-cannulated rats.
    Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:8

    Topics: Absorption; Adenosine; Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Catheterization; Dibenzocycloheptenes; Diketopiperazines; Heterocyclic Compounds, 4 or More Rings; Male; Portal Vein; Quinolines; Rats; Rats, Sprague-Dawley; Sulfasalazine; Terfenadine; Topotecan

2013